000			02230 a2200577 4500
005			20250513123542.0
264		0	_c19970908
008			199709s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1997.15.8.2966 _2doi
040			_aNLM _beng _cNLM
100	1		_aLofters, W S
245	0	0	_aPhase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cAug 1997
300			_a2966-73 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAntiemetics _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndoles _xadverse effects
650	0	4	_aInjections, Intravenous
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNausea _xchemically induced
650	0	4	_aOndansetron _xadverse effects
650	0	4	_aPremedication
650	0	4	_aQuality of Life
650	0	4	_aQuinolizines _xadverse effects
650	0	4	_aVomiting _xchemically induced
700	1		_aPater, J L
700	1		_aZee, B
700	1		_aDempsey, E
700	1		_aWalde, D
700	1		_aMoquin, J P
700	1		_aWilson, K
700	1		_aHoskins, P
700	1		_aGuevin, R M
700	1		_aVerma, S
700	1		_aNavari, R
700	1		_aKrook, J E
700	1		_aHainsworth, J
700	1		_aPalmer, M
700	1		_aChin, C
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 15 _gno. 8 _gp. 2966-73
856	4	0	_uhttps://doi.org/10.1200/JCO.1997.15.8.2966 _zAvailable from publisher's website
999			_c9235816 _d9235816